Plant extract may treat lupus disease

Image
IANS New York
Last Updated : Sep 25 2014 | 2:26 PM IST

A plant-derived chemical may help treat the deadly lupus disease - a progressive, degenerative disease in which a person's immune system attacks healthy tissue, cells and organs.

The latest work by biomedical engineers including an Indian-origin scientist Chandra Mohan from University of Houston (UH) could lead to new, more natural therapeutics for lupus.

In latest research, Mohan and his colleagues found a synthetic, plant-derived compound - CDDO - that was shown to effectively suppress lupus development during animal testing - including the onset of kidney disease.

"The development of lupus is a two-step reaction. First, the immune system develops antibodies that attack the body's DNA, then that activated immune system attacks the kidneys," Mohan said.

"We found that CDDO may block both of these steps," he added.

Researchers also found that the CDDO compound had no known side effects

The next step is to confirm whether the CDDO compound suppresses the immune system across the board or whether it simply suppresses the activation of the specific signalling pathways that lead to the development of lupus.

With only one drug specifically approved for the treatment of lupus in the past 50 years, lupus patients are commonly treated with steroids, a class of immunosuppressive drugs.

At least five million people worldwide are suffering from lupus.

The findings were published in the journal Arthritis & Rheumatology.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 25 2014 | 2:12 PM IST

Next Story